New Stock News | Jiangxi Biotech Port IPO and domestic unlisted shares "fully circulated" approved by the China Securities Regulatory Commission
On April 30, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice on the filing of overseas issuance and listing of Jiangxi Bio-products Research Institute Co., Ltd. and the 'full circulation' of domestically unlisted shares".
On April 30th, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice on the Filing for the Overseas Issuance and Listing of Jiangxi Biochemical Research Institute Co., Ltd. and the 'Full Circulation' of Unlisted Domestic Shares." The company plans to issue up to 104,321,500 shares of overseas listed common stock and list them on the Hong Kong Stock Exchange. 47 shareholders of the company plan to convert a total of 270,855,819 unlisted domestic shares into overseas listed shares and make them trade on the Hong Kong Stock Exchange.
Related Articles
7ROAD (00797) spent HK$95,000 to repurchase 160,000 shares on May 7th.
China XD Electric (601179.SH) subsidiary wins bid for 1.583 billion yuan national power grid project.
LI AUTO (02015) spent $4.04 million to repurchase 457,500 shares on May 6th.
7ROAD (00797) spent HK$95,000 to repurchase 160,000 shares on May 7th.
China XD Electric (601179.SH) subsidiary wins bid for 1.583 billion yuan national power grid project.
LI AUTO (02015) spent $4.04 million to repurchase 457,500 shares on May 6th.
